news aktuell GmbH

eutecma GmbH: Cool Concept for International Logistics

Share

Mannheim/Germany-based eutecma GmbH with Second Location in the USA.

Eutecmas modular Cold Chain Systems with Circular Economy Technology in North America
Eutecmas modular Cold Chain Systems with Circular Economy Technology in North America

(Mannheim/Germany) – Mannheim/Germany-based eutecma GmbH is expanding its presence on the North American continent. Following the opening of a refreshment center in Springfield/Ohio last year, the eutecma corporation is now cooperating with a US partner in Wisconsin, the Badger State near the Canadian border, to manufacture environmentally friendly EPS shipping boxes according to eutecma standards.

As a global operator in the packaging sector, eutecma supplies shipping boxes with volumes ranging from 4 to 1588 liters for three different temperature ranges, all assembled from modular components. These boxes are primarily used by customers in the pharmaceutical industry to ship temperature-sensitive products. After utilization, the recipients return the boxes, which are fitted with RFID chips (Radio Frequency Identification), to a refreshment center. Once there, a fully automatic system measures and weighs them, as well as checking that all box parameters comply with the relevant specifications. The goal is to re-use the boxes as many times as possible, deploying them within a circular economy. The cloud-based retecma system provides the customer with information on how many times the boxes and cooling elements have already been used and how much CO2 has been saved. Parts that are in good working order are disinfected with UV radiation and, if necessary, steam cleaned. All damaged components are removed and sent to a recycling company that refurbishes them to create new modules. The result? No loss of materials and virtually zero emissions, reducing CO2 by 97 percent.

To see these cold chain systems, visit LogiPharma, the world’s premier event for global pharmaceutical supply chains and logistics, in Boston from September 23 through 25.

Contacts

Images

Eutecmas modular Cold Chain Systems with Circular Economy Technology in North America
Eutecmas modular Cold Chain Systems with Circular Economy Technology in North America
Download
After utilization, the recipients return the boxes, which are fitted with RFID chips (Radio Frequency Identification), to a refreshment center. There, a fully automatic system measures and weighs them to re-use the boxes as many times as possible, deploying them within a circular economy.
After utilization, the recipients return the boxes, which are fitted with RFID chips (Radio Frequency Identification), to a refreshment center. There, a fully automatic system measures and weighs them to re-use the boxes as many times as possible, deploying them within a circular economy.
Download

About news aktuell GmbH

news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Vyoma’s first Space Domain Awareness satellite has reached orbit13.1.2026 13:42:00 CET | Press release

Munich, 13. January 2026 - Vyoma, a Germany-based company providing Space Domain Awareness (SDA) capabilities, has launched its pioneering surveillance satellite, Flamingo-1, on Sunday, January 11th, 2026 from Vandenberg Space Force Base, California, USA. It was launched aboard the Twilight rideshare mission with SpaceX via Germany-based launch integrator Exolaunch. The satellite was deployed to its operational Sun-synchronous orbit of approximately 500-km in altitude. This marks a significant achievement for the company, which patented the operational concept of an optimized SDA mission. Flamingo-1, equipped with an optical sensor for space-based space surveillance, is a gamechanger for Europe, strengthening SDA efforts directly from orbit. The advanced optical instrument will detect, track and characterize space objects, such as debris and other satellites. Crucially, it will allow Vyoma and its customers to follow up on manoeuvring objects and derive insights into adversary actions

Acousia Announces Completion of Patient Enrollment in Phase 2 PROHEAR Study Evaluating ACOU085 (INN: Bimokalner) for the Prevention of Cisplatin-Induced Ototoxicity8.1.2026 09:00:00 CET | Press release

Tübingen, Germany, January 8, 2026 Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced the completion of patient enrollment in its Phase 2 PROHEAR clinical study. ACOU085 (INN: Bimokalner) is a proprietary, first-in-class small molecule that has demonstrated robust and reproducible efficacy across multiple preclinical hearing loss models, including drug-induced ototoxicity. The PROHEAR Study is a double-blind, randomized, placebo-controlled, split-body, multicenter Phase 2 trial. It enrolled young male patients with metastatic testicular cancer who are scheduled to receive cisplatin-based chemotherapy. While cisplatin is a highly effective chemotherapeutic agent, cumulative doses of ≥300 mg/m² lead to clinically meaningful, permanent hearing loss in the majority of patients. Fifteen leading university hospitals in Germany are participating in this interdisciplinary study. Patients are randomized

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye